Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_assertion type Assertion NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_head.
- NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_assertion description "[Two hundred and ninety-three patients were enrolled in two randomized trials comparing stenting plus abciximab with thrombolysis (alteplase alone or alteplase plus abciximab) in AMI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_provenance.
- NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_assertion evidence source_evidence_literature NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_provenance.
- NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_assertion SIO_000772 16175011 NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_provenance.
- NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_assertion wasDerivedFrom befree-20150227 NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_provenance.
- NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_assertion wasGeneratedBy ECO_0000203 NP628804.RA_ABoZ8gJRZ6w3rSMkbW0aomXUUzaqK9lkF426qcjqBc130_provenance.